Literature DB >> 29984795

Efficacy of microsurgery in Reinke's oedema evaluated by traditional voice assessment integrated with the Vocal Extent Measure (VEM).

T Salmen1, T Ermakova2, A Schindler3, S-R Ko1, Ö Göktas1, M Gross1, T Nawka1, P P Caffier1.   

Abstract

SUMMARY: There are few data analysing to what specific extent phonomicrosurgery improves vocal function in patients suffering from Reinke's oedema (RE). The recently introduced parameter vocal extent measure (VEM) seems to be suitable to objectively quantify vocal performance. The purpose of this clinical prospective study was to investigate the outcomes of phonomicrosurgery in 60 RE patients (6 male, 54 female; 56 ± 8 years ([mean ± SD]) by analysing its effect on subjective and objective vocal parameters with particular regard to VEM. Treatment efficacy was evaluated at three months after surgery by comparing pre- and postoperative videolaryngostroboscopy (VLS), auditory-perceptual assessment (RBH-status), voice range profile (VRP), acoustic-aerodynamic analysis and patient's self-assessment using the voice handicap index (VHI-9i). Phonomicrosurgically, all RE were carefully ablated. VLS revealed removal or substantial reduction of oedema with restored periodic vocal fold vibration. All subjective and most objective acoustic and aerodynamic parameters significantly improved. The VEM increased on average from 64 ± 37 to 88 ± 25 (p #x003C; 0.001) and the dysphonia severity index (DSI) from 0.5 ± 3.4 to 2.9 ± 1.9. Both parameters correlated significantly with each other (rs = 0.70). RBH-status revealed less roughness, breathiness and overall grade of hoarseness (2.0 ± 0.7 vs 1.3 ± 0.7). The VHI-9i-score decreased from 18 ± 8 to 12 ± 9 points. The average total vocal range enlarged by 4 ± 7 semitones, and the mean speaking pitch rose by 2 ± 4 semitones. These results confirm that: (1) the use of VEM in RE patients objectifies and quantifies their vocal capacity as documented in the VRP, and (2) phonomicrosurgery is an effective, objectively and subjectively satisfactory therapy to improve voice in RE patients.
Copyright © 2018 Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Phonomicrosurgery; Reinke’s oedema; Vocal Extent Measure (VEM); Voice function diagnostics; Voice range profile quantification

Mesh:

Year:  2018        PMID: 29984795      PMCID: PMC6036954          DOI: 10.14639/0392-100X-1544

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  33 in total

1.  Reinke's edema: phonatory mechanisms and management strategies.

Authors:  S M Zeitels; R E Hillman; G W Bunting; T Vaughn
Journal:  Ann Otol Rhinol Laryngol       Date:  1997-07       Impact factor: 1.547

2.  Smoking cessation in chronic Reinke's oedema.

Authors:  P E Højslet; V Moesgaard-Nielsen; M Karlsmose
Journal:  J Laryngol Otol       Date:  1990-08       Impact factor: 1.469

3.  Influence of age and gender on the dysphonia severity index. A study of normative values.

Authors:  Marieke M Hakkesteegt; Michael P Brocaar; Marjan H Wieringa; Louw Feenstra
Journal:  Folia Phoniatr Logop       Date:  2006       Impact factor: 0.849

Review 4.  [Benign vocal fold lesions].

Authors:  A Pickhard; R Reiter
Journal:  Laryngorhinootologie       Date:  2013-01-24       Impact factor: 1.057

5.  A comparison of white light laryngostroboscopy versus autofluorescence endoscopy in the evaluation of vocal fold pathology.

Authors:  Philipp P Caffier; Bernd Schmidt; Manfred Gross; Klaus Karnetzky; Tadeus Nawka; Andreas Rotter; Matthias Seipelt; Benedikt Sedlmaier
Journal:  Laryngoscope       Date:  2013-04-22       Impact factor: 3.325

6.  Postsurgical follow-up study of patients with severe polypoid degeneration.

Authors:  S M Lumpkin; S Bennett; S G Bishop
Journal:  Laryngoscope       Date:  1990-04       Impact factor: 3.325

7.  The dysphonia severity index: an objective measure of vocal quality based on a multiparameter approach.

Authors:  F L Wuyts; M S De Bodt; G Molenberghs; M Remacle; L Heylen; B Millet; K Van Lierde; J Raes; P H Van de Heyning
Journal:  J Speech Lang Hear Res       Date:  2000-06       Impact factor: 2.297

8.  Reinke's edema and risk factors: clinical and histopathologic aspects.

Authors:  Dario Marcotullio; Giuseppe Magliulo; Tiziana Pezone
Journal:  Am J Otolaryngol       Date:  2002 Mar-Apr       Impact factor: 1.808

9.  Cigarette smoke and reactive oxygen species metabolism: implications for the pathophysiology of Reinke's edema.

Authors:  Ryan C Branski; Benjamin Saltman; Lucian Sulica; Hazel Szeto; Suzy Duflo; Diane Felsen; Dennis H Kraus
Journal:  Laryngoscope       Date:  2009-10       Impact factor: 3.325

Review 10.  Diagnostic and therapeutic pitfalls in benign vocal fold diseases.

Authors:  Jörg Bohlender
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13
View more
  4 in total

1.  Two-handed tying technique in vocal fold mucosa microsuture for the treatment of Reinke's edema.

Authors:  Faya Liang; Renhui Chen; Peiliang Lin; Pin Han; Qian Cai; Xiaoming Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-23       Impact factor: 2.503

2.  Pathology-Related Influences on the VEM: Three Years' Experience since Implementation of a New Parameter in Phoniatric Voice Diagnostics.

Authors:  Constanze Müller; Felix Caffier; Tadeus Nawka; Matthias Müller; Philipp P Caffier
Journal:  Biomed Res Int       Date:  2020-12-21       Impact factor: 3.411

3.  Monitoring the Outcome of Phonosurgery and Vocal Exercises with Established and New Diagnostic Tools.

Authors:  Matthias Seipelt; Andreas Möller; Tadeus Nawka; Ute Gonnermann; Felix Caffier; Philipp P Caffier
Journal:  Biomed Res Int       Date:  2020-01-23       Impact factor: 3.411

4.  Distribution and Appearance of Ki-67, IL-1α, IL-10, and PGP 9.5 in Reinke's Oedema-Affected Larynx Tissue Compared with Control Tissue.

Authors:  Vita Konopecka; Mara Pilmane; Dins Sumerags; Gunta Sumeraga
Journal:  Life (Basel)       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.